BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 19793677)

  • 21. [Gastrointestinal stromal tumor (GIST): pathology in continuous development. Diagnostic-therapeutic strategies].
    Sianesi M
    Ann Ital Chir; 2009; 80(4):257-60. PubMed ID: 19967882
    [No Abstract]   [Full Text] [Related]  

  • 22. On the reliability of mitotic count on biopsy samples of gastrointestinal stromal tumors.
    Ricci R; Chiarello G; Vanella G; Larghi A
    Eur J Surg Oncol; 2014 Apr; 40(4):484-5. PubMed ID: 24486075
    [No Abstract]   [Full Text] [Related]  

  • 23. Treatment of gastrointestinal stromal tumors--initial experience.
    Lupaşcu C; Andronic D; Moldovanu R; Târcoveanu E; Georgescu S; Ferariu D
    Chirurgia (Bucur); 2010; 105(5):657-62. PubMed ID: 21141090
    [TBL] [Abstract][Full Text] [Related]  

  • 24. NCCN Task Force report: gastrointestinal stromal tumor (GIST).
    Demetri G; DeMatteo RP
    J Natl Compr Canc Netw; 2004 Sep; 2 Suppl 3():S-25-8. PubMed ID: 23570095
    [No Abstract]   [Full Text] [Related]  

  • 25. On the reliability of mitotic count on biopsy samples of gastrointestinal stromal tumors.
    Cananzi FC
    Eur J Surg Oncol; 2014 Apr; 40(4):486. PubMed ID: 24486076
    [No Abstract]   [Full Text] [Related]  

  • 26. Imatinib adjuvant therapy after surgical excision of gastrointestinal stromal tumour.
    Prescrire Int; 2011 Feb; 20(113):38. PubMed ID: 21488587
    [No Abstract]   [Full Text] [Related]  

  • 27. Role of surgery combined with kinase inhibition in the management of gastrointestinal stromal tumor (GIST).
    Hohenberger P; Eisenberg B
    Ann Surg Oncol; 2010 Oct; 17(10):2585-600. PubMed ID: 20407930
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Surgical treatment of locally advanced, non-metastatic, gastrointestinal stromal tumours after treatment with imatinib.
    Tielen R; Verhoef C; van Coevorden F; Gelderblom H; Sleijfer S; Hartgrink HH; Bonenkamp JJ; van der Graaf WT; de Wilt JH
    Eur J Surg Oncol; 2013 Feb; 39(2):150-5. PubMed ID: 23084087
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [New prospective on adjuvant treatment for gastrointestinal stromal tumors].
    Pan ZZ; Wu XJ
    Zhonghua Wei Chang Wai Ke Za Zhi; 2013 Mar; 16(3):212-5. PubMed ID: 23536337
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gastrointestinal stromal tumor of the rectum: results of surgical and multimodality therapy in the era of imatinib.
    Jakob J; Mussi C; Ronellenfitsch U; Wardelmann E; Negri T; Gronchi A; Hohenberger P
    Ann Surg Oncol; 2013 Feb; 20(2):586-92. PubMed ID: 22965573
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Electronic clinical challenges and images in GI. Cystic GIST of the lesser omentum.
    Ouazzani A; Lefebvre JC; Mefire Y; Guérin E; Dryjski J; Vaneukem P
    Gastroenterology; 2008 Jun; 134(7):e1-2. PubMed ID: 18485902
    [No Abstract]   [Full Text] [Related]  

  • 32. Management of gastrointestinal stromal tumor: the imatinib era and beyond.
    Parikh PM; Gupta S
    Indian J Cancer; 2013; 50(1):31-40. PubMed ID: 23713042
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recurrent GI bleeding and surgery following the initial response to imatinib therapy in GIST of the stomach.
    El Hajj II; Chehal A; El Saghir NS
    Dig Dis Sci; 2005 Jan; 50(1):65-9. PubMed ID: 15712639
    [No Abstract]   [Full Text] [Related]  

  • 34. GI Stromal Tumors: 15 Years of Lessons From a Rare Cancer.
    Cioffi A; Maki RG
    J Clin Oncol; 2015 Jun; 33(16):1849-54. PubMed ID: 25918303
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Treatment of metastatic gastrointestinal stromal tumors with Imatinib: report of four cases].
    Garrido S M; Moneada M M; Tapia N G; Méndez O G; Galindo A H; Huete G A; Ibáñez A L; González S; Alvarez Z M
    Rev Med Chil; 2007 Oct; 135(10):1327-32. PubMed ID: 18180842
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Surgical treatment of an advanced GIST the age of imatinib].
    Fernández JA; Parrilla P
    Cir Esp; 2009 Jul; 86(1):3-12. PubMed ID: 19539273
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic analysis of patients with gastrointestinal stromal tumors: a single unit experience with surgical treatment of primary disease.
    Cao H; Zhang Y; Wang M; Shen DP; Sheng ZY; Ni XZ; Wu ZY; Liu Q; Shen YY; Song YY
    Chin Med J (Engl); 2010 Jan; 123(2):131-6. PubMed ID: 20137358
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Outcome of metastatic GIST in the era before tyrosine kinase inhibitors.
    Gold JS; van der Zwan SM; Gönen M; Maki RG; Singer S; Brennan MF; Antonescu CR; De Matteo RP
    Ann Surg Oncol; 2007 Jan; 14(1):134-42. PubMed ID: 17080234
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tumor rupture exposes the patient to an increased risk of relapse, regardless of the size and number of mitoses.
    Quintero CB; Cubedo R
    Anticancer Drugs; 2012 Jun; 23 Suppl():S1-2. PubMed ID: 22739664
    [No Abstract]   [Full Text] [Related]  

  • 40. Current management of GIST.
    Blanke C
    Clin Adv Hematol Oncol; 2004 May; 2(5):280, 283. PubMed ID: 17682286
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.